Precision Medicine in Hormone Receptor-Positive Breast Cancer

In recent decades, breast cancer has become largely manageable due to successes with hormone receptor targeting. Hormone receptor-positive tumors have favorable outcomes in comparison to estrogen receptor (ESR1, ER)/progesterone receptor-negative tumors given the targetable nature of these tumors, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Nasrazadani, Azadeh, Thomas, Roby A., Oesterreich, Steffi, Lee, Adrian V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5945817/
https://www.ncbi.nlm.nih.gov/pubmed/29780747
http://dx.doi.org/10.3389/fonc.2018.00144

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5945817/
https://www.ncbi.nlm.nih.gov/pubmed/29780747
http://dx.doi.org/10.3389/fonc.2018.00144

Ejemplares similares